Company
NOWDiagnostics (NOWDx)
a leader in developing over-the-counter (OTC) and point-of-care (POC) diagnostic tests
Also known as NOWDiagnostics, Inc., NOWDx
- Status
- Operatingas of 2026-09-18
- Business model
- B2C
- Customers
- At-Risk Consumers
- Legal name
- NOWDiagnostics, Inc.
- nowdx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We develop and manufacture “Touch to Test” over-the-counter and point of care diagnostic tests that yield results in minutes. Our patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or in some cases, saliva. We envision a world where people have greater access to in-home testing with in-home results – in minutes. We are committed to changing healthcare by providing accessible, affordable, and accurate testing for all.
Funding snapshot
- Total raised
- $43.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series B, $22.5M
Funding rounds
- Round, 2019
- $19M2019-12-09, SEC form D sold, 18 investors
- Round, 2018
- $13.2M2018-06-29, SEC form D sold, 5 investors
- Round, 2016
- $10.9M2016-06-20, SEC form D sold, 24 investors
- Round, 2015
- 2015-02-04
- Round, 2014
- 2014-08-29
- Round, 2014
- 2014-03-05
- Round, 2013
- $25K2013-03-08, SEC form D sold, 1 investor
- Series B
- $22.5MCompany stated
Products
- Hardware
- ADEXUSDx hCG Test
Loading relationship preview